Eugene

[email protected]

LATEST

Novartis’ Gene-Therapy Company AveXis To Build $55-Million Plant
By

By
Novartis’ AveXis, a Bannockburn, Illinois-based clinical-stage gene-therapy company, plans to invest $55 million to build a new manufacturing center in Research Triangle Park, Durham County, North Carolina. Novartis acquired AveXis…

AstraZeneca Opens New R&D Site
By

By
AstraZeneca has opened a new research and development (R&D) site in South San Francisco, California. This follows the company’s September 2016 announcement of plans to bring together five of its…

Astellas Plans Restructuring and 600 Job Cuts in Japan
By

By
Astellas Pharma plans to restructure its operations in Japan, which includes the discontinuation and divestment of certain subsidiaries as well as the introduction of an early-retirement incentive program, for which…

Dipharma Completes Acquisition of CRO Kalexsyn
By

By
Dipharma, a Baranzate, Italy-headquartered active pharmaceutical ingredients manufacturer, has completed its previously announced acquisition of Kalexsyn, a Kalamazoo, Michigan-headquartered contract research organization (CRO) providing chemistry services to the biotechnology and…

FDA Issues Complete Response Letter to Evolus for Manufacturing Issues for Botox Competitor
By

By
The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) over manufacturing issues to Evolus, an Irvine, California-based medical-aesthetics company, relating to its pending biologics license…

Celgene, Evotec in Oncology Drug Pact
By

By
Celgene and Evotec, a Hamburg, Germany-based drug-discovery and development company, have entered into a long-term drug discovery and development partnership to identify new therapeutics in oncology. Evotec’s preclinical discovery and…

West Introduces New Analytical Services
By

By
West Analytical Services, part of West Pharmaceutical Services, is investing in new analytical capabilities to enable customers to pair new and more complex drug products with the right containment systems,…

Catalent Completes $5.5 Million Clinical-Storage Expansion
By

By
Catalent Pharma Solutions has completed the second phase of a $5.5-million expansion program at its Kansas City, Missouri facility to increase the controlled-substance and controlled-temperature storage capabilities for its clinical…

WuXi Biologics, Bioasis in Supply Pact
By

By
WuXi Biologics, part of WuXi AppTec, a contract service provider, has partnered with Bioasis Technologies, a Richmond, British Columbia, Canada-based biopharmaceutical company focused on drug-delivery across the brain–blood barrier, to…

GE Increases Cell-Culture Media Production
By

By
GE Healthcare Life Sciences is increasing the annual production capacity of its powdered cell-culture media by tenfold at its facility in Pasching, Austria. GE is also doubling its powdered cell-culture…